Preoperative hypoglycemia in a patient receiving insulin detemir

Anesthesia and Analgesia

Volumn 108, Issue 6, 2009, Pages 1836-1838

  Olson, Ronald P ^a,d   Bethel, M Angelyn ^b,c   Lien, Lillian ^b,c  

^a Department of Anesthesiology ^*  (United States)

^b Dept Obstet Gynecol Duke U   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ESOMEPRAZOLE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INFUSION FLUID; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLULISINE; PARACETAMOL; PREGABALIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN;

ABDOMINAL PAIN; ADULT; CASE REPORT; CLINICAL PROTOCOL; COMORBIDITY; EVENING DOSAGE; FEMALE; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; GYNECOLOGIC SURGERY; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; POSTOPERATIVE NAUSEA AND VOMITING; POSTPRANDIAL STATE; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; ARTICLE; BLOOD; BODY MASS; CHEMICALLY INDUCED DISORDER; DIET RESTRICTION; METABOLISM; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PREOPERATIVE CARE;

EID: 66349113745     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181a2a777     Document Type: Article

References (17)

1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67
2. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001;79:207-14
3. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-32
4. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-21
5. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults. JAMA 2008;300:933-44
6. Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006;141:375-80
7. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007;146:233-43
8. Smiley DD, Umpierrez GE. Perioperative glucose control in the diabetic or nondiabetic patient. South Med J 2006;99:557-8
9. Reinhart L, Panning CA. Insulin glargine: a new long-acting insulin product. Am J Health Syst Pharm 2002;59:643-9
10. Detemir Summary of Product Characteristics. http://www. levemir-us.com/prescribing-information.pdf, accessed March 24, 2009
11. Goldman-Levine JD, Lee KW. Insulin detemir - a new basal insulin analog. Ann Pharmacother 2005;39:502-7
12. Heise T, Nosek L, Ronn BB, Endahl L, Heinemann L, Kapitza C, Draeger E. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004;53:1614-20
13. Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes. Diabetes Obes Metab 2007;9:290-9
14. Mooradian AD, Bernbaum M, Albert SG. Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 2006;145:125-34
15. Lien LF, Angelyn Bethel M, Feinglos MN. In-hospital management of type 2 diabetes mellitus. Med Clin North Am 2004;88:1085-105, xii
16. Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr 2007;86:7-13
17. Donahi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006;12:358-62